Perrigo Net Income 2010-2024 | PRGO

Perrigo net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Perrigo Annual Net Income
(Millions of US $)
2023 $-13
2022 $-141
2021 $-69
2020 $-163
2019 $146
2018 $131
2017 $120
2016 $-4,013
2015 $43
2015 $136
2014 $233
2013 $442
2012 $402
2011 $339
2010 $224
2009 $146
Perrigo Quarterly Net Income
(Millions of US $)
2024-03-31 $2
2023-12-31 $-32
2023-09-30 $14
2023-06-30 $8
2023-03-31 $-3
2022-12-31 $-24
2022-09-30 $-49
2022-06-30 $-65
2022-03-31 $-2
2021-12-31 $10
2021-09-30 $-59
2021-06-30 $-58
2021-03-31 $38
2020-12-31 $-175
2020-09-30 $-155
2020-06-30 $61
2020-03-31 $106
2019-12-31 $-19
2019-09-30 $92
2019-06-30 $9
2019-03-31 $64
2018-12-31 $82
2018-09-30 $-68
2018-06-30 $36
2018-03-31 $81
2017-12-31 $73
2017-09-30 $45
2017-06-30 $-70
2017-03-31 $72
2016-12-31 $-1,359
2016-09-30 $-1,590
2016-06-30 $-534
2016-03-31 $-529
2015-12-31 $-174
2015-09-30 $261
2015-06-30 $-22
2015-03-31 $-22
2014-12-31 $70
2014-09-30 $96
2014-06-30
2014-03-31 $48
2013-12-31 $-86
2013-09-30 $111
2013-06-30
2013-03-31 $112
2012-12-31 $106
2012-09-30 $106
2012-06-30
2012-03-31 $116
2011-12-31 $100
2011-09-30 $70
2011-06-30
2011-03-31 $89
2010-12-31 $90
2010-09-30 $74
2010-06-30
2010-03-31 $62
2009-12-31 $61
2009-09-30 $52
2009-06-30
2009-03-31 $46
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.501B $4.656B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $180.765B 23.67
Stryker (SYK) United States $129.618B 31.04
Boston Scientific (BSX) United States $112.981B 35.99
Medtronic (MDT) Ireland $100.927B 15.11
EssilorLuxottica (ESLOY) France $99.128B 0.00
Lonza Group Ag (LZAGY) Switzerland $40.586B 0.00
Haleon (HLN) United Kingdom $37.716B 27.53
ResMed (RMD) United States $28.121B 26.40
Terumo (TRUMY) Japan $24.403B 34.46
Koninklijke Philips (PHG) Netherlands $22.841B 18.13
Zimmer Biomet Holdings (ZBH) United States $22.328B 14.26
Baxter (BAX) United States $17.045B 12.12
Insulet (PODD) United States $14.134B 62.67
Smith & Nephew SNATS (SNN) United Kingdom $10.833B 0.00
Demant (WILYY) Denmark $9.370B 0.00
Bio-Rad Laboratories (BIO) United States $7.790B 25.48
BellRing Brands (BRBR) United States $7.453B 35.06
Lantheus Holdings (LNTH) United States $5.565B 13.87
GN Store Nord (GNNDY) Denmark $4.222B 23.71
Haemonetics (HAE) United States $4.215B 20.79
Prestige Consumer Healthcare (PBH) United States $3.437B 16.35
Neogen (NEOG) United States $3.386B 32.56
ICU Medical (ICUI) United States $2.893B 25.54
Envista Holdings (NVST) United States $2.858B 11.79
TG Therapeutics (TGTX) United States $2.749B 77.35
Green Thumb Industries (GTBIF) United States $2.552B 49.96
Agios Pharmaceuticals (AGIO) United States $2.448B 0.00
QuidelOrtho (QDEL) United States $2.225B 12.35
LeMaitre Vascular (LMAT) United States $1.847B 54.13
Maravai LifeSciences Holdings (MRVI) United States $1.804B 0.00
Warby Parker (WRBY) United States $1.592B 0.00
InMode (INMD) Israel $1.532B 8.14
AdaptHealth (AHCO) United States $1.332B 9.90
Verano Holdings (VRNOF) United States $1.246B 0.00
AtriCure (ATRC) United States $1.084B 0.00
Owens & Minor (OMI) United States $1.033B 9.00
National Vision Holdings (EYE) United States $1.028B 32.72
BioLife Solutions (BLFS) United States $0.987B 0.00
Cresco Labs (CRLBF) United States $0.771B 0.00
Phibro Animal Health (PAHC) United States $0.679B 14.46
Evolus (EOLS) United States $0.679B 0.00
PetIQ (PETQ) United States $0.656B 21.21
VAREX IMAGING (VREX) United States $0.602B 14.16
Surmodics (SRDX) United States $0.599B 37.54
Quanterix (QTRX) United States $0.506B 0.00
ZimVie (ZIMV) United States $0.498B 42.44
Canopy Growth (CGC) Canada $0.491B 0.00
Valneva SE (VALN) France $0.488B 0.00
Biote (BTMD) United States $0.463B 10.67
Jin Medical (ZJYL) China $0.403B 0.00
TerrAscend (TSNDF) Canada $0.394B 0.00
Cerus (CERS) United States $0.325B 0.00
OraSure Technologies (OSUR) United States $0.315B 10.14
Zynex (ZYXI) United States $0.296B 40.52
MacroGenics (MGNX) United States $0.266B 0.00
Viemed Healthcare (VMD) United States $0.254B 25.19
Aurora Cannabis (ACB) Canada $0.252B 0.00
Sanara MedTech (SMTI) United States $0.243B 0.00
Utah Medical Products (UTMD) United States $0.236B 14.85
Omeros (OMER) United States $0.235B 0.00
Ayr Wellness (AYRWF) United States $0.233B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Holdings (OGI) Canada $0.160B 0.00
FitLife Brands (FTLF) United States $0.153B 21.76
Capricor Therapeutics (CAPR) United States $0.153B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
Quipt Home Medical (QIPT) United States $0.137B 0.00
Veru (VERU) United States $0.123B 0.00
Jushi Holdings (JUSHF) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.104B 0.00
Fonar (FONR) United States $0.101B 10.26
Brainsway (BWAY) Israel $0.101B 0.00
InterCure (INCR) Israel $0.092B 15.46
Cellectar Biosciences (CLRB) United States $0.090B 0.00
Chimerix (CMRX) United States $0.079B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.073B 4.75
MariMed (MRMD) United States $0.069B 0.00
Safety Shot (SHOT) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.053B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Zevia PBC (ZVIA) United States $0.049B 0.00
Bright Green (BGXX) United States $0.048B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Apyx Medical (APYX) United States $0.046B 0.00
United-Guardian (UG) United States $0.041B 14.90
Cytosorbents (CTSO) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Exagen (XGN) United States $0.032B 0.00
Nephros (NEPH) United States $0.022B 0.00
Meihua Medical Technologies (MHUA) China $0.021B 0.00
Agape ATP (ATPC) $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.016B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
FSD PHARMA (HUGE) Canada $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.001B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00